As of 2024-12-14, the Relative Valuation of SQZ Biotechnologies Co (SQZ) is (48.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of SQZ Biotechnologies Co based on Relative Valuation is -11187.7%.
The range of the Relative Valuation is (45.86) - (50.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 24.1x | 17.3x |
| Forward P/E multiples | 12.3x - 18.9x | 18.5x |
| Fair Price | (45.86) - (50.82) | (48.23) |
| Upside | -10642.6% - -11782.4% | -11187.7% |
| Date | P/E |